2-Methyl-3-butyn-2-ol → 10-(3-Hydroxy-3-methylbut-1-yn-1-yl)-3-(((2-methoxyethyl)(methyl)amino)methyl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine-2-carboxamide
Reaction equation
Br[C:2]1[CH:3]=[CH:4][C:5]2[O:11][CH2:10][CH2:9][N:8]3[C:12]([CH2:18][N:19]([CH2:21][CH2:22][O:23][CH3:24])[CH3:20])=[C:13]([C:15]([NH2:17])=[O:16])[N:14]=[C:7]3[C:6]=2[CH:25]=1.BrC1C=CC2OCCN3C(CN4CCCC4)=C(C(N)=O)N=C3C=2C=1.COCCNC.[CH3:56][C:57]([OH:61])([C:59]#[CH:60])[CH3:58]>>[OH:61][C:57]([CH3:58])([CH3:56])[C:59]#[C:60][C:2]1[CH:3]=[CH:4][C:5]2[O:11][CH2:10][CH2:9][N:8]3[C:12]([CH2:18][N:19]([CH2:21][CH2:22][O:23][CH3:24])[CH3:20])=[C:13]([C:15]([NH2:17])=[O:16])[N:14]=[C:7]3[C:6]=2[CH:25]=1Participants
5
Reactant 4
Product 1
Procedure
Similar to as described in General Procedure G, 10-bromo-3-(((2-methoxyethyl)(methyl)amino)methyl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine-2-carboxamide (prepared similarly as described in the synthesis of 10-bromo-3-(pyrrolidin-1-ylmethyl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine-2-carboxamide replacing pyrrolidine with 2-methoxy-N-methylethanamine) was reacted with 2-methylbut-3-yn-2-ol to give the titled compound as a colorless solid (20 mg, 20%).
Workup
- customprepared similarly
Sources & evidence
- ORD record
- ord-85a6bc3106ab4daba0c5e2ecb8ced129
- Source dataset
- uspto-grants-2015_05
- Patent number
- US09034866B2
Reaction notes
Loading…